Source: BioPortfolio

Gemphire Therapeutics: Gemphire Therapeutics Inc GEMP Financial and Strategic SWOT Analysis Review Published by Global Data Prices from USD $125

Gemphire Therapeutics Inc GEMP Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased vie...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Stephen Gullans's photo - President & CEO of Gemphire Therapeutics

President & CEO

Stephen Gullans

CEO Approval Rating

90/100

Read more